
Bortezomib For Injection - Reversible 26s Proteasome Inhibitor | Approved For Multiple Myeloma Treatment
Get Latest Price
In Stock
Product Specifications
| Application | Bolus injection |
| Dosage | 2 mg/vial |
| Features | Cancer treatment, Proteasome inhibitor, Intravenous injection, Single use, Multiple myeloma |
| Manufacturer | Cadila Pharmaceuticals |
| Packaging | Single vial |
| Route of Administration | Intravenous |
| Storage | Refrigerated |
| Usage | Treats multiple myeloma |
Product Overview
Key Features
Company Details
Business Type
Exporter, Distributor
Employee Count
100
Establishment
1987
Working Days
To
Payment Mode
Western Union
Related Products
More Products From This Seller
Seller Details
Palghar, Maharashtra
Accepts only Foreign inquiries
Name
Jiten Aggarwal
Address
Address: H.301 Maxheal house, tarapur industrial area, Dist. Palghar, Maharashtra, 401506, India
bortezomib in Palghar
Report incorrect details

![(2S)-N-[(1S)-1-Hydroxy-3-Methylbutyl]-3-Phenyl-2-(Pyrazin-2-Ylformamido)Propanamide;(S)-Hydroxy Des(Boric Acid) Bortezomib - Cas No: 289472-81-7](https://cpimg.tistatic.com/10413417/b/4/-2S-N-1S-1-hydroxy-3-methylbutyl-3-phenyl-2-pyrazin-2-ylformamido-propanamide-S-Hydroxy-Des-boric-Acid-Bortezomib.jpg)
























